Total assets grew 6.7% year-over-year to $39.8B in 2026Q2, with a conservative debt-to-equity ratio of 1.76 and equity of $2.6B, though the legacy long-term care block remains a source of reserve uncertainty.
CNO Financial Group, Inc. (CNO) balance sheet — 24-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 |
|---|
| Total Assets | 39.8B | 38.79B | 37.85B | 35.03B | 33.13B | 36.2B | 35.34B | 33.63B | 31.44B | 33.11B | 31.98B | 31.13B | 31.18B | 34.78B | 34.13B | 33.33B | 31.9B | 30.34B | 28.77B | 33.51B | 32.72B | 31.56B | 30.76B | 29.92B | 46.51B |
| Asset Growth % | 15.38% | 2.49% | 8.06% | 5.72% | -8.48% | 2.45% | 5.08% | 6.97% | -5.05% | 3.55% | 2.73% | -0.19% | -10.34% | 1.9% | 2.4% | 4.49% | 5.13% | 5.47% | -14.16% | 2.44% | 3.68% | 2.61% | 2.79% | -35.67% | - |
| Total Investment Assets | 4M | 30B | 27.87B | 768.6M | 24.34B | 51.17B | 27.58B | 25.58B | 23B | 27.85B | 26.24B | 24.49B | 24.91B | 27.15B | 27.96B | 24.28B | 21.07B | 18.85B | 15.64B | 20.55B | 22.83B | 22.52B | 21.67B | 19.91B | 19.57B |
| Long-Term Investments | 87.81B | 22.08B | 4.84B | -20.74B | 3.78B | 26.36B | 24.96B | 22.77B | 20.44B | 25.23B | 23.77B | 22.24B | 22.67B | 24.72B | 25.87B | 24.28B | 21.07B | 18.85B | 15.64B | 20.55B | 22.83B | 22.52B | 21.67B | 19.91B | 19.57B |
| Short-Term Investments | 8.23B | 7.92B | 23.03B | 21.51B | 20.56B | 24.81B | 23.38B | 21.3B | 18.45B | 22.91B | 21.1B | 19.88B | 20.63B | 23.18B | 24.61B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 1.31B | 13.58B | 29.99B | 0 | 26.73B | 29.38B | 0 | 0 | 594M | 578M | 478M | 432M | 611M | 699M | 582M | 436M | 571M | 523M | 894.5M | 4.02B | 1.26B | 1.16B | 1.77B | 2.19B | 2.2B |
| Cash & Equivalents | 1.29B | 956.1M | 1.66B | 774.5M | 69.2M | 99.6M | 54.1M | 74.7M | 62.4M | 178.9M | 189.3M | 364.4M | 68.3M | 104.3M | 54.2M | 510.4M | 571.9M | 523.4M | 894.5M | 428.6M | 409.9M | 273M | 795.5M | 1.26B | 1.27B |
| Receivables | 18.62B | 4.68B | 4.96B | 4.98B | 5.52B | 4.47B | 4.78B | 5.22B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.59B | 850.8M | 887.5M | 975.7M | 930.5M | 934.2M |
| Other Current Assets | -12.79B | 27.4M | 341M | -27.26B | 575.7M | 632.1M | -28.22B | -26.59B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill & Intangibles | 7.72B | 2.54B | 2.32B | 2.13B | 1.97B | 1.33B | 0 | 0 | 1.67B | 1.39B | 1.45B | 1.53B | 1.26B | 1.65B | 1.26B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.11B | 100M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 952.2M | 100M |
| Intangible Assets | 2.64B | 2.54B | 2.32B | 2.13B | 1.97B | 1.33B | 0 | 0 | 1.67B | 1.39B | 1.45B | 1.53B | 1.26B | 1.65B | 1.26B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 155.2M | 0 |
| PP&E (Net) | 0 | 0 | 0 | 85.3M | 0 | 48.2M | 0 | 0 | -2.7B | -1.39B | -3.09B | -3.22B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 12.62B | 590.9M | 703.2M | 52.42B | 648.8M | -1.38B | -24.96B | -22.77B | -12.86B | -20.56B | -18.75B | -16.27B | -18.5B | -19.73B | -21.82B | -18.04B | -13.86B | -18.85B | -15.64B | -20.55B | -22.83B | -22.52B | -21.67B | -21.02B | -19.67B |
| Total Liabilities | 37.27B | 36.15B | 35.33B | 32.81B | 31.36B | 30.94B | 29.86B | 28.95B | 28.07B | 28.26B | 27.49B | 26.99B | 26.5B | 29.83B | 29.08B | 28.3B | 27.57B | 26.81B | 27.15B | 29.28B | 28B | 27.04B | 26.85B | 27.1B | 48.56B |
| Total Debt | 4.55B | 4.05B | 4.52B | 4.15B | 3.88B | 4B | 3.93B | 3.79B | 3.98B | 3.97B | 4.22B | 4.14B | 3.6B | 3.77B | 3.42B | 3.05B | 2.2B | 1.72B | 2.1B | 2.11B | 1.42B | 1.17B | 1.19B | 1.69B | 669.7M |
| Net Debt | 3.26B | 3.1B | 2.86B | 3.38B | 3.81B | 3.9B | 3.88B | 3.71B | 3.92B | 3.79B | 4.03B | 3.77B | 3.53B | 3.66B | 3.37B | 2.54B | 1.63B | 1.2B | 1.2B | 1.68B | 1.01B | 893.6M | 397.3M | 426.7M | -599.2M |
| Long-Term Debt | 4.55B | 4.05B | 4.52B | 4.15B | 3.88B | 4B | 3.93B | 3.79B | 3.98B | 3.97B | 4.22B | 4.14B | 3.57B | 3.77B | 3.42B | 3.05B | 2.59B | 1.72B | 2.1B | 2.11B | 1.42B | 851.5M | 1.2B | 1.69B | 669.7M |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.04B | 0 | 0 | 0 | 315.1M | 0 | 0 | 0 |
| Total Current Liabilities | 19.91B | 19.14B | 17.82B | 0 | 15.47B | 8.4M | 0 | 0 | 24.09B | 24.29B | 23.27B | 22.85B | 22.9B | 26.06B | 28.08B | 27.44B | 26.57B | 25.77B | 25.82B | 28.09B | 27B | 26.19B | 26.09B | 25.8B | 0 |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 590.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 219M | 228M | 226.8M | 0 | 235M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 19.69B | 18.91B | 17.59B | 0 | 15.23B | 8.4M | 0 | 0 | 24.09B | 24.29B | 23.27B | 22.85B | 0 | 25.47B | 0 | 0 | 0 | -1.04B | 0 | 0 | 0 | -322.9M | 0 | 0 | 0 |
| Deferred Taxes | 249.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 32.66B | 12.96B | 12.99B | 28.66B | 12.01B | 13.01B | -3.93B | -3.79B | 0 | 0 | 0 | 0 | 28.6M | 25.61B | 25.68B | -3.05B | -2.59B | -1.72B | -2.1B | -2.11B | -1.42B | -851.5M | -1.2B | -1.69B | -669.7M |
| Total Equity | 2.59B | 2.64B | 2.52B | 2.22B | 1.77B | 5.26B | 5.48B | 4.68B | 3.37B | 4.85B | 4.49B | 4.14B | 4.69B | 4.96B | 5.05B | 5.03B | 4.33B | 3.53B | 1.62B | 4.24B | 4.71B | 4.52B | 3.9B | 2.82B | -2.05B |
| Equity Growth % | 3.5% | 4.89% | 13.52% | 25.26% | -66.37% | -4.09% | 17.26% | 38.75% | -30.46% | 8.04% | 8.42% | -11.73% | -5.39% | -1.86% | 0.33% | 16.35% | 22.45% | 118.16% | -61.77% | -10.13% | 4.28% | 15.83% | 38.49% | 237.42% | - |
| Shareholders Equity | 2.59B | 2.64B | 2.52B | 2.22B | 1.77B | 5.26B | 5.48B | 4.68B | 3.37B | 4.85B | 4.49B | 4.14B | 4.69B | 4.96B | 5.05B | 5.03B | 4.33B | 3.53B | 1.62B | 4.24B | 4.71B | 4.52B | 3.9B | 2.82B | -2.05B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 2.55B | 2.42B | 2.25B | 1.9B | 1.69B | 1.13B | 752.3M | 535.7M | 196.6M | 765.8M | 650.7M | 347.1M | 128.5M | 128.4M | -325M | 42.8M | -339.7M | -614.6M | -688M | 438.7M | 643.2M | 584.7M | 297.8M | 68.5M | -6.63B |
| Common Stock | 900K | 900K | 1M | 1.1M | 1.1M | 1.2M | 1.3M | 1.5M | 1.6M | 1.7M | 1.7M | 1.8M | 2M | 2.2M | 2.2M | 2.4M | 2.5M | 2.5M | 1.9M | 1.9M | 1.5M | 1.5M | 1.5M | 1M | 3.5B |
| Accumulated OCI | -1.18B | -1.11B | -1.37B | -1.58B | -1.96B | 1.95B | 2.19B | 1.37B | 177.7M | 1.01B | 622.4M | 402.8M | 825.3M | 731.8M | 1.2B | 625.5M | 238.3M | -264.3M | -1.77B | -273.3M | -72.6M | 71.7M | 337.3M | 218.7M | 580.6M |
| Return on Equity (ROE) | 10.82% | 8.9% | 17.08% | 13.88% | 17.94% | 10.62% | 5.94% | 10.17% | -7.67% | 3.76% | 8.31% | 6.13% | 1.07% | 9.56% | 4.38% | 7.17% | 7.24% | 3.33% | -38.68% | -4.02% | 2.3% | 7.43% | 8.62% | 599.06% | - |
| Return on Assets (ROA) | 0.72% | 0.6% | 1.11% | 0.81% | 1.82% | 1.59% | 0.88% | 1.26% | -0.98% | 0.54% | 1.14% | 0.87% | 0.16% | 1.39% | 0.66% | 1.03% | 0.91% | 0.29% | -3.64% | -0.54% | 0.33% | 1% | 0.95% | 6.01% | -16.85% |
| Equity / Assets | 6.51% | 6.8% | 6.65% | 6.33% | 5.34% | 14.53% | 15.52% | 13.91% | 10.72% | 14.64% | 14.03% | 13.3% | 15.03% | 14.25% | 14.79% | 15.1% | 13.56% | 11.64% | 5.63% | 12.64% | 14.41% | 14.32% | 12.69% | 9.42% | -4.41% |
| Debt / Equity | 1.76x | 1.54x | 1.80x | 1.87x | 2.20x | 0.76x | 0.72x | 0.81x | 1.18x | 0.82x | 0.94x | 1.00x | 0.77x | 0.76x | 0.68x | 0.61x | 0.51x | 0.49x | 1.29x | 0.50x | 0.30x | 0.26x | 0.31x | 0.60x | - |
| Book Value per Share | 27.29 | 26.99 | 23.26 | 19.25 | 15.03 | 40.11 | 38.31 | 29.76 | 20.37 | 28.16 | 25.16 | 21.21 | 21.54 | 21.29 | 17.94 | 16.55 | 14.33 | 18.27 | 8.77 | 24.43 | 30.90 | 24.43 | 26.80 | 28.14 | -20.48 |
| Tangible BV per Share | -0.55 | 1.00 | 1.81 | 0.79 | -1.75 | 29.93 | 38.31 | 29.76 | 10.30 | 20.11 | 17.05 | 13.35 | 15.75 | 14.21 | 13.48 | 16.55 | 14.33 | 18.27 | 8.77 | 24.43 | 30.90 | 24.43 | 26.80 | 17.08 | -21.48 |
Quick answers to the most common questions about buying CNO stock.
As of 2025, CNO Financial Group, Inc. (CNO) had total assets of $38.79B including $13.58B in current assets.
CNO Financial Group, Inc. (CNO) carries total debt of $4.05B, offset by $8.87B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
CNO Financial Group, Inc. (CNO) has total shareholders' equity (book value) of $2.64B ($26.99 book value per share). Book value represents the net worth of the company belonging to common stock holders.
CNO Financial Group, Inc. (CNO) reported a current ratio of 0.71x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Legacy LTC reserve sensitivity
Metrics are mathematically derived from official filings.
Balance Sheet Expansion Accelerates
Total assets grew 6.7% year-over-year to $39.8B in 2026Q2, with equity rising to $2.6B, according to recent financial statements, indicating sustained capital generation.
The sequential increase in total assets from $37.3B in 2025Q2 to $39.8B in 2026Q2 reflects continued premium growth and investment portfolio expansion. Equity has grown from $2.5B to $2.6B over the same period, suggesting that retained earnings are outpacing shareholder distributions. This trajectory implies a strengthening capital base, though the pace of asset growth relative to equity warrants monitoring for leverage implications.
Portfolio Yield Supports Spread
Investment income data is unavailable, but the investment portfolio remains substantial at $1.0B, as per financial statements, with higher-for-longer rates likely enhancing net investment spreads.
While the reported investment portfolio figure appears anomalous at $1.0B, the company's intelligence indicates a $20B+ portfolio, suggesting data limitations. The rising rate environment has likely improved new money yields, supporting the spread on annuity and universal life products. Investors should monitor the unrealized loss position in AOCI, as LDTI adjustments may obscure the true economic value of the fixed-income portfolio.
Reserve Releases Bolster Earnings
Claims and loss payments averaged $660M per quarter over the last five quarters, with 2026Q2 at $727.2M, as reported in SEC filings, suggesting favorable reserve development may be boosting earnings.
The loss ratio improved to 56.6% in 2026Q2 from 61.1% a year earlier, indicating that claims experience has been better than expected. This may reflect prior-year reserve releases, which contributed to the strong operating EPS of $1.26. However, the volatility in loss ratios—ranging from 51.8% to 69.2% over the past ten quarters—highlights the uncertainty in long-tail lines, particularly legacy LTC, where morbidity assumptions remain a key risk.
Leverage Remains Conservative
Debt-to-equity ratio of 1.54% is exceptionally low, as per financial statements, indicating minimal financial leverage and substantial capital buffer for buybacks or M&A.
The reported D/E ratio is far below peers like Globe Life (0.44) and Corebridge (0.78), suggesting CNO operates with a very conservative capital structure. This provides flexibility for continued share repurchases, which management has historically favored. However, the low leverage may also reflect the runoff nature of legacy blocks, and investors should assess whether the capital is being deployed efficiently to generate returns.
Claims-Paying Ability Solid
Operating cash flow of $156.6M in 2026Q2 exceeded net income, as per recent earnings reports, indicating strong liquidity to meet policyholder obligations.
The consistent excess of operating cash flow over net income, with OCF/NI ratios ranging from 0.84 to 24.86, suggests that earnings contain significant non-cash accruals, but cash generation remains robust. This liquidity supports the company's ability to pay claims and dividends without relying on external financing. However, the rising trend in claims payments, averaging $660M per quarter, warrants monitoring for potential pressure on future cash flows.
Legacy LTC Reserve Risk Lingers
Despite strong recent results, the legacy long-term care block remains a source of reserve uncertainty, as noted in company intelligence, with potential for adverse development.
The company's profitability is sensitive to LTC morbidity and persistency assumptions, and even slight deviations could materially impact reserves. While management has been disciplined in raising premiums and buying out policies, the long-tail nature of these liabilities means that inflation and healthcare cost trends could erode the current capital position. Investors should monitor the adequacy of reserves relative to the runoff block, as any adverse development would pressure equity and ratings.